March 03, 2015 5:39 PM ET


Company Overview of Apexigen Inc.

Company Overview

Apexigen Inc. operates as a biopharmaceutical product development company. It focuses on development of product candidates for life-threatening and difficult to treat diseases. The company’s products include humanized antibodies for cancer, inflammatory diseases, and ophthalmic diseases. It discovers and develops rabbit-derived humanized monoclonal antibodies. The company was founded in 2010 and is based in Burlingame, California.

863 Mitten Road

Suite 103

Burlingame, CA 94010-1303

United States

Founded in 2010





Key Executives for Apexigen Inc.

Chief Executive Officer, President and Director
Vice President of Finance
Vice President of Business Development
Director of Preclinical Development and Clinical Research
Vice President of Clinical Development
Compensation as of Fiscal Year 2014.

Apexigen Inc. Key Developments

Apexigen, Inc. Appoints Ovid C. Trifan as Vice President, Clinical Development and Amy Wong as Vice President, Finance

Apexigen Inc. announced the appointments of Ovid C. Trifan, MD, PhD as Vice President, Clinical Development and Amy Wong as Vice President, Finance. Dr. Trifan previously held the position of Senior Medical Director in the Clinical Science group at Onyx Pharmaceuticals. Ms. Wong previously held the position of Vice President, Finance, Human Resources and Operations at

Apexigen Inc. Presents at 2013 BIO Convention in China, Nov-12-2013 04:00 PM

Apexigen Inc. Presents at 2013 BIO Convention in China, Nov-12-2013 04:00 PM. Venue: China National Convention Center, No.7 Tianchen East Road, Chaoyang District, Beijing 100105, China.

George J. Lee Joins the Board of Directors of Apexigen Inc

Apexigen Inc. announced that it has secured $20 million in Series A1 financing. Series A-1 financing was led by Amkey Ventures LLC and the major investors include WSR Capital, China Development Industrial Bank, Themes Investment Partners, and Sycamore Ventures. In conjunction with the financing, George J. Lee, Ph.D., General Partner of Amkey Ventures, has joined Apexigen's Board of Directors.

Similar Private Companies By Industry

Company Name Region
THERACELL United States
Radix Bio Solutions Ltd. United States
Cencor Biotech Inc. United States
Imutran United States
Mariposa Biotechnology, Inc. United States

Recent Private Companies Transactions

No transactions available in the past 12 months.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Apexigen Inc., please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at